TELESAT PRIOR-HF: a major publication in the European Journal of Heart Failure.
The period following hospitalization for heart failure is one of the most critical moments in the patient journey. Published in the European Journal of Heart Failure, TELESAT PRIOR-HF focuses precisely on this high-risk population: patients who had experienced at least one hospitalization for heart failure in the year before inclusion.
This new publication documents, in real-world conditions, the association between Satelia® Cardio remote patient monitoring, in addition to standard care, and improved clinical outcomes, including reductions in all-cause mortality, heart failure hospitalizations, emergency department visits and intensive care unit admissions.
TELESAT PRIOR-HF provides new real-world evidence on the role of patient-centered remote monitoring during the post-hospitalization phase of heart failure care.
TELESAT PRIOR-HF, published in the European Journal of Heart Failure.
An analysis focused on high-risk patients.
TELESAT PRIOR-HF is a prespecified sub-analysis of the TELESAT-HF study. It analyzes data from heart failure patients who had experienced at least one heart failure hospitalization in the year before inclusion. This population is particularly exposed to the risk of new clinical events, making it a key group for evaluating the potential contribution of structured remote follow-up.
After weighting, the analysis compared:
- 1,258 patients monitored with Satelia® Cardio in addition to standard care
- 2,321 patients receiving standard care alone
The objective was to assess the association between patient-centered remote monitoring and major clinical outcomes: all-cause mortality, heart failure hospitalizations, emergency department visits, intensive care unit admissions, cumulative length of hospital stay and healthcare costs.
TELESAT PRIOR-HF study design: comparison between Satelia® Cardio remote monitoring and standard care.
Significant real-world clinical outcomes.
In recently hospitalized heart failure patients, Satelia® Cardio, in addition to standard care, was associated with:
- 46% lower all-cause mortality
- 15% fewer heart failure hospitalizations
- 32% fewer emergency department visits
- 35% fewer intensive care unit admissions
- a reduced cumulative length of hospital stay, with an estimated absolute difference of -1.77 days
Another important finding: mean healthcare costs were comparable between groups. These results therefore document an association between patient-centered remote monitoring and improved clinical outcomes, without a significant increase in mean observed healthcare costs.
A strong signal for post-hospitalization follow-up.
Hospital discharge is a vulnerable period for patients with heart failure. It requires structured follow-up, close coordination between healthcare professionals and the ability to identify risk situations early. TELESAT PRIOR-HF provides an important perspective on this phase of the care pathway. The study suggests that patient-centered remote monitoring may contribute to strengthening post-hospitalization follow-up, in addition to standard care, in a particularly fragile population. These results are part of a broader dynamic: documenting, through real-world evidence, the role of remote monitoring in the organization of heart failure care pathways.
This publication was authored by Luca Monzo, Patrick Jourdain, Annabelle Jagu, Marie-France Seronde, Hélène Benchimol, Jean-Michel Tartière, Olivier Hanon, Stéphane Lafitte, Vanessa Barbet, Nicolas Pages, Sophie Nisse-Durgeat, François Picard and Nicolas Girerd.
It represents an important contribution to the evaluation of patient-centered remote monitoring in heart failure, particularly among high-risk patients after hospitalization.
Learn more.
The full publication is available in the European Journal of Heart Failure.
Click here to download the study PDF
